FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Related Tags >> FDA regulation   Alcon
Syndicate content

Retaane News

Most Popular Retaane Story

Alcon faces setback on experimental AMD therapy

Shares of Alcon slipped this morning after the eye care giant announced that the FDA would require another trial of its experimental therapy for wet, age-related macular degeneration. Researchers... Read more...

Latest Headlines